HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NED-180

inhibits melanogenesis; structure in first source

Also Known As:

3-(4-(tert-butyl)phenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Acrylamides: 12
    - NED-180: 1
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acrylates: 212
      - Acrylamides: 12
        NED-180: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Dioxanes
    - NED-180: 1

Experts

1.	Hwang, Eunson: 1 article (01/2016)
2.	Kim, Sanghee: 1 article (01/2016)
3.	Kim, Sun Yeou: 1 article (01/2016)
4.	Lee, Taek Hwan: 1 article (01/2016)
5.	Lee, Wook-Joo: 1 article (01/2016)
6.	Shim, Won-Sik: 1 article (01/2016)
7.	Yeo, Eui-Ju: 1 article (01/2016)

Related Diseases

1.	Hyperpigmentation 01/01/2016 - "Furthermore, topical application of NED-180 significantly ameliorated UVB-induced skin hyperpigmentation in guinea pigs. " 01/01/2016 - "A novel synthetic Piper amide derivative NED-180 inhibits hyperpigmentation by activating the PI3K and ERK pathways and by regulating Ca2+ influx via TRPM1 channels."

Related Drugs and Biologics

1.	Amides